Skip to main content
padlock icon - secure page this page is secure

Clinical features of Fabry's disease in Australian patients

Buy Article:

$52.00 + tax (Refund Policy)

Abstract Background: 

Anticipating the prospect of specific treatment, we studied a large group of Australians with Fabry's disease. Aims:

We aimed to: (i) document the clinical ­features of Fabry's disease in Australian patients, (ii) test the hypothesis that clinical features vary with specific mutation and blood group and (iii) assess small-fibre peripheral nerve function. Methods:

A questionnaire was forwarded to all Australian patients known to us. Patients were invited to attend for clinical, renal cardiac, ophthalmological and neurological assessment. Results:

Sixty-seven patients (29 men and 38 women) from 18 families participated. Diagnosis in index cases was delayed by ≥10 years in nearly all families. Common clinical features are: (i) episodic acropar­aesthesia (100% of hemizygotes; 53% of heterozygotes), (ii) anhydrosis (93%; 1%), (iii) characteristic rash (93%; 13%), (iv) renal disease (69%; 21%), (v) ischaemic heart disease (28%; 26%), (vi) palpitations (62%; 29%), (vii) mitral valve murmurs (37%; 23%) and (viii) premature cerebro­vascular disease (31%; 5%). Ophthalmic findings of cornea verticillata (96%; 76%) and anterior cataract (48%; 14%) were common. Findings were variable within and between families. In women, anhydrosis reliably predicts the presence of significant Fabry's renal disease. Small nerve fibre testing using quantitative sensory testing was clearly abnormal in 95% of male patients, and in those female patients with para­esthesiae. Conclusions:

Symptoms of anhydrosis, acroparaesthesiae, rash and renal disease suggest diagnosis of Fabry’s. Women are commonly symptomatic, and the advent of therapy highlights the practical advantage of earlier diagnosis. (Intern Med J 2002; 32: 575−584)
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: Fabry's disease; Quantitative Sensory Testing; alpha-galactosidase; cornea verticillata; ­vascular disease

Document Type: Original Article

Affiliations: 1: Nephrology, 2: 2Cardiology 3: Neurology and 4: Ophthalmology, The Royal Melbourne Hospital, Melbourne, Victoria, Australia

Publication date: December 1, 2002

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more